India faces a rapidly worsening antimicrobial resistance crisis driven by multidrug-resistant bacteria, weak surveillance, ...

A new experimental antibiotic has stunned researchers by wiping out dangerous bacteria at concentrations roughly two orders ...

A recent WHO report outlined concerning changes in the antibacterial pipeline — namely, that the pipeline is shrinking and ...

Researchers employed a technique that can allow the discovery of novel microbiome-produced metabolites not seen under standard laboratory conditions.

The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.

DelveInsight's, “Familial Chylomicronemia Syndrome Pipeline Insights 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Familial Chylomicronemia Syndrome pipeline ...

But at the United Nations high-level meeting on AMR) in 2024, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus, PhD, highlighted another side of the problem that has ...

Developer of a new class of synthetic anti-infectives, Recce Pharmaceuticals has been granted its Family 4 patent in Hong Kong, extending protection through to 2041.

This paper aims to critique the argument constructed by Anna Smajdor and Joona Räsänen that pregnancy is a disease. Their argument that pregnancy fits the features of disease they enumerate stems from ...

The global syndrome therapeutics market size was valued at US$ 147.4 Mn in 2024 and is projected to reach US$ 407.3 Mn by ...

Syndax Pharmaceuticals, Inc. ( SNDX) The 67th American Society of Hematology ( ASH) Annual Meeting December 8, 2025 7:00 AM EST ...